Oxygen-evolving hollow polydopamine alleviates tumour hypoxia for enhancing photodynamic therapy in cancer treatment

Qichen Zhan,Xuan Han,Jiankang Mu,Xianqing Shi,Yuhan Zheng,Ting Wang,Tao Cao,Yulu Xi,Zhongpei Weng,Xiaoqing Wang,Peng Cao,Jian-kang Mu
DOI: https://doi.org/10.1039/d2na00549b
IF: 5.598
2022-10-19
Nanoscale Advances
Abstract:Hypoxia, a characteristic hallmark of solid tumours, restricts the therapeutic effect of photodynamic therapy (PDT) for cancer treatment. To address this issue, a facile and nanosized oxygen (O2) bubbles template is established by mixing oxygenated water and water-soluble solvents for guiding hollow polydopamine (HPDA) synthesis, and O2 is encapsulated in the cavity of HPDA. HPDA with abundant catechol is designed as carrier for Zinc phthalocyanine (ZnPc, a boronic acid modified photosensitizer) via borate ester bonds to fabricate nanomedicine (denoted HZNPs). The results in vitro and in vivo indicate O2-evolving HZNPs could alleviate tumour hypoxia and enhance PDT-anticancer efficiency. Melanin-like HPDA with photothermal conversion rate (η) of 38.2% shows excellent synergistic photothermal therapy (PTT) efficiency in cancer treatment.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?